Bioteque Corporation (TPEX:4107)

Market Cap	8.18B
Revenue (ttm)	2.07B
Net Income (ttm)	528.26M
Shares Out	69.30M
EPS (ttm)	7.59
PE Ratio	15.55
Forward PE	15.21
Dividend	5.00 (4.27%)
Ex-Dividend Date	Jul 30, 2024

Volume	24,991
Average Volume	148,501
Open	117.50
Previous Close	117.00
Day's Range	117.50 - 118.50
52-Week Range	101.00 - 147.50
Beta	0.33
RSI	46.65
Earnings Date	May 9, 2025

About Bioteque

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine c...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4107

Financial Performance

In 2024, Bioteque's revenue was 2.07 billion, an increase of 6.58% compared to the previous year's 1.94 billion. Earnings were 528.26 million, an increase of 16.73%.